Analysis of operative efficacy for giant pituitary adenoma

BMC Surgery

Yinxing Huang¹  Lin Zhao¹  Liangfeng Wei¹  Shun’an Lin¹  Shousen Wang¹ 

[1] Department of Neurosurgery, Fuzhou General Hospital, Fujian Medical University, No.156 Xihuanbei Road, Fuzhou 350025, P. R. China

关键词: Resection rate;    Operative efficacy;    Transsphenoidal surgery;    Microsurgery;    Tumor volume;    MR imaging;    Giant pituitary adenoma;   

Others  :  1118371
DOI  :  10.1186/1471-2482-14-59

 received in 2013-12-16, accepted in 2014-08-20,  发布年份 2014

【 摘 要 】

Background

Surgical treatment of giant pituitary adenomas is difficult due to complicated dissection of the sellar area. The extent of tumor resection affects the efficacy of surgical treatment. This study is to investigate the efficacy of microsurgical treatment for giant pituitary adenoma and to analyze the relationship between treatment efficacy and tumor resection extent.

Methods

A retrospective analysis was performed in 36 patients who received microsurgery to remove giant pituitary adenomas. The sizes of tumors before and after surgery were calculated with a novel method called the “platform-like volume calculation formula”. The relationships between extent of resection and the visual impairment recovery, and improvement of serum hormone level before and after operation were analyzed.

Results

Two deaths were observed after surgery. And the gross and near-total resection was achieved in 8 cases, subtotal resection in 8 cases, mostly partial resection in 15 cases, and partial resection in 5 cases. The average resection rate was 72.8%. The resection rate of tumor with cavernous sinus invasion was significantly lower than those of patients without cavernous sinus invasion (P < 0.05). The improvement rate of hormone level in functional adenoma was 80.0%. Follow-up observations were carried out for 3 ~ 28 months in 25 cases. Visual improvement was observed in 64.0% of the cases.

Conclusions

Microsurgical treatment can improve the visual impairment of the majority of cases and significantly decrease the serum hormone levels of functional adenoma. The extent of resection was significantly associated with cavernous sinus invasion.

【 授权许可】

   
2014 Wang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Jho HD, Carrau RL, Ko Y, Daly MA: Endoscopic pituitary surgery: an early experience. Surg Neurol 1997, 47:213-222.
• [2]Shrivastava RK, Arginteanu MS, King WA, Post KD: Giant prolactinomas: clinical management and long-term follow up. J Neurosurg 2002, 97:299-306.
• [3]Goel A, Nadkarni T, Muzumdar D, Desai K, Phalke U, Sharma P: Giant pituitary tumors: a study based on surgical treatment of 118 cases. Surg Neurol 2004, 61:436-445.
• [4]Müslüman AM, Cansever T, Yılmaz A, Kanat A, Oba E, Cavusoǧlu H, Sirinoǧlu D, Aydın Y: Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes. World Neurosurg 2011, 76:141-148.
• [5]Gondim JA, Almeida JPC, Albuquerque LAF, Gomes EF, Schops M: Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach. World Neurosurg 2013. doi:10.1016/j.wneu.2013.08.028
• [6]Komotar RJ, Starke RM, Raper DMS, Anand VK, Schwartz TH: Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary 2012, 15:150-159.
• [7]Koutourousiou M, Gardner PA, Fernandez-Miranda JC, Paluzzi A, Wang EW, Snyderman CH: Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations. J Neurosurg 2013, 118:621-631.
• [8]Sankhla SK, Jayashankar N, Khan GM: Surgical management of selected pituitary macroadenomas using extended endoscopic endonasal transsphenoidal approach: early experience. Neurol India 2013, 61:122-130.
• [9]Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Muller OA, Fahlbusch R: Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 2008, 108:9-18.
• [10]Laws ER: Surgery for acromegaly: evolution of the techniques and outcomes. Rev Endocr Metab Disord 2008, 9:67-70.
• [11]Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr: The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 2002, 96:195-208.
• [12]Romano A, Chibbaro S, Marsella M, Oretti G, Spiriev T, Iaccarino C, Servadei F: Combined endoscopic transsphenoidal–transventricular approach for resection of a giant pituitary macroadenoma. World Neurosurg 2010, 74:161-164.
• [13]Mitsumori M, Shrieve DC, Alexander E 3rd, Kaiser UB, Richardson GE, Black PM, Loeffler JS: Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 1998, 42:573-580.
• [14]Mortini P, Barzaghi R, Losa M, Boari N, Giovanelli M: Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery 2007, 60:993-1002. 1003–1004
• [15]Sinha S, Sharma BS: Giant pituitary adenomas–an enigma revisited. Microsurgical treatment strategies and outcome in a series of 250 patients. Br J Neurosurg 2010, 24:31-39.
• [16]Wu ZB, Su ZP, Wu JS, Zheng WM, Zhuge QC, Zhong M: Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion. Pituitary 2008, 11:63-70.
• [17]Gondim JA, de Almeida JP, de Albuquerque LA, Schops M, Gomes E, Ferraz T: Headache associated with pituitary tumors. J Headache Pain 2009, 10:15-20.
• [18]Agrawal A, Cincu R, Goel A: Current concepts and controversies in the management of non-functioning giant pituitary macroadenomas. Clin Neurol Neurosurg 2007, 109:645-650.
• [19]Buchfelder M: Treatment of pituitary tumors: surgery. Endocrine 2005, 28:67-75.
• [20]Chacko G, Chacko AG, Lombardero M, Mani S, Seshadri MS, Kovacs K, Scheithauer BW: Clinicopathologic correlates of giant pituitary adenomas. J Clin Neurosci 2009, 16:660-665.
• [21]Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF: The endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience. Neurosurgery 2008, 63:244-256.